🟢 Tenaya Therapeutics is trading 10.68% up in pre-market — no clear company-specific catalyst identified

Tenaya Therapeutics is trading 10.68% up in pre-market at $0.76, up from the September 1, 2026 close of $0.69; no clear catalyst identified.

• No company-specific September 2 or September 1 announcement was identified.
• Latest official release: August 5, covering second-quarter results and a business update; additional clinical data and regulatory updates are anticipated in Q4 2026. The broader market is slightly weaker, and low-priced biotech activity or delayed reaction may be factors; causation is unconfirmed.